查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1445436

藥用玻璃包裝 - 市場佔有率分析、行業趨勢與統計、成長預測（2024 - 2029）

Pharmaceutical Glass Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年藥用玻璃包裝市場規模預計為297.7億美元，預計到2029年將達到385.2億美元，在預測期內（2024-2029年）CAGR為5.29%。

藥用玻璃包裝 - 市場

玻璃包裝解決方案主要作為藥品的初級包裝提供，是製藥業領先的包裝材料之一。這主要是由於其具有永續、惰性、不滲透、可回收、不損失品質和可重複使用的優點。

主要亮點

  • 隨著製藥業技術進步，對藥品和藥物的需求不斷成長，直接創造了對瓶子、安瓿和其他玻璃包裝解決方案的需求。
  • 隨著慢性病的增加以及生產大量針對 COVID-19 的疫苗劑量，預計對初級包裝的需求將會增加，尤其是玻璃容器。
  • 此外，玻璃的顯著特性優勢，例如化學耐久性和適合維持各種化學成分，是推動包裝供應商選擇玻璃作為製藥材料的一些因素。此外，玻璃小瓶和安瓿瓶的透明度更高，方便檢視和監控內容物。
  • 傳統上，藥品包裝的首選材料是鋁和玻璃。隨著時間的推移，由於原料價格和其他因素，這些材料變得昂貴，並且無法為大眾消費的包裝產品提供經濟可行的解決方案。這標誌著塑膠作為一種選擇的出現。
  • COVID-19 大流行帶來了穩定的成長率和藥品需求的增加。疫情期間藥品需求激增帶動了市場成長。隨著藥品製造商在不同國家批准和逐步淘汰新藥和疫苗，玻璃包裝的範圍不斷擴大，預計玻璃包裝的應用範圍將會擴大。

藥用玻璃包裝市場趨勢

新興經濟體醫藥產業成長拉動經濟成長

  • 新興市場被描述為日益繁榮的國家，儘管風險巨大，但投資仍有望增加利潤。BRICS（巴西、俄羅斯、印度、中國和南非）是最大的發展中經濟體。對低皆經濟體進行分類有幾種不同的方法。僅使用少數國家作為 MIST（墨西哥、印尼、韓國和土耳其）。另一種解釋將這兩個群體分為CIVETS（哥倫比亞、印尼、越南、埃及、土耳其和南非）和孟加拉、埃及、印尼、伊朗、韓國、墨西哥、奈及利亞、巴基斯坦、菲律賓、土耳其和越南。
  • 儘管許多已開發國家的藥品銷售成長緩慢，但新興市場的銷售模式顯示其持續擴張。一些經濟和人口變數影響著這些市場的趨勢，例如成熟市場的挑戰性條件（由於專利到期而導致成長趨於平緩），鼓勵學名藥替代的成本削減措施以及嚴格執行限制。
  • 藥用玻璃包裝產業在中國等國家已顯著滲透。藥品玻璃包裝在已開發國家的應用越來越廣泛。受新冠肺炎（COVID-19）影響，新興國家的醫療保健和製藥行業不斷成長，這為中國藥用玻璃包裝市場帶來了潛力。
  • 例如，2022年9月，SCHOTT Pharma擴大了在中國的藥筒產量。數百萬美元的投資目的是顯著提高中國和匈牙利的藥筒製造能力。
  • 此外，研發在印度製藥業也受到高度重視。印度透過擴大研發生態系統和增加藥品出口，於2022年成為全球醫療巨頭，為國內各玻璃包裝供應商創造了機會。
  • 總體而言，由於製藥市場的成長，重要市場現有企業的所有這些投資預計將在預測期內推動市場成長。

亞太地區將見證顯著成長

  • 隨著中國多年來為製藥業建立了標準體系，中國藥用玻璃包裝市場預計將快速成長。國家越來越重視藥品包裝材料在藥品儲存期間的穩定性和使用時的安全性。在此背景下，新型綠色、可分解、使用方便的藥用包裝材料和容器迎來了蓬勃發展的時代。
  • 由於大型跨國製藥公司的存在，中國龐大且快速成長的醫療保健市場一直是中國玻璃包裝產業明顯的機會目標，而這些公司是中國製藥市場中最重要的收入來源。
  • 在印度，由於醫療保健產業通用注射藥物的使用不斷增加，藥用玻璃包裝不斷成長。藥用玻璃包裝有多種藥物類型，例如注射劑和非注射劑。藥用玻璃包裝的顯著特性是具有高化學耐久性，最大限度地提高產品的可靠性。
  • 由於印度是全球藥品市場中的重要且不斷擴大的參與者，預計印度對玻璃包裝的需求將快速成長。印度品牌資產基金會網站公佈的資料顯示，印度是全球最大的學名藥供應國，佔全球供應量的20%，滿足全球60%以上的疫苗需求。印度製藥業的全球價值為 420 億美元。印度醫藥市場在2021年 8月較去年同期擴張 17.7%，高於2020年 7月的 13.7%。根據 India Ratings & Research 的資料，印度醫藥市場營收在2022 會計年度將成長 12%以上。
  • 在日本，最終用途市場玻璃容器出貨量的增加支撐了市場的成長。玻璃容器是包裝液體藥品、化學品和各種其他易腐爛/不易腐爛產品的最優選材料之一。此外，人們對環保包裝解決方案的日益青睞也影響了藥用玻璃包裝的採用。
  • 亞太其他地區範圍包括印尼、澳洲、新加坡、泰國、韓國、馬來西亞等多個國家。該市場是由國際合作夥伴關係的激增、生物學名藥、成品製劑出口的擴大以及強勁的學名藥市場推動的。

藥用玻璃包裝產業概況

藥用玻璃包裝市場趨於分散化。政府措施的激增以及對注射劑和其他藥品的需求不斷增加，為藥用玻璃包裝解決方案提供了利潤豐厚的機會。整體而言，現有競爭對手之間的競爭激烈。此外，不同製藥業大公司的擴張和合併預計將增加市場需求。主要參與者有 Gerresheimer Glass Inc.、Corning Incorporated 等。

2022年 9月，Gerresheimer AG 和 StevanatoGroup SpA 共同開發了高階即用型（RTU）解決方案平台，最初致力於基於 StevanatoGroup 市場領先的 EZ-fill 技術構建的小瓶。客戶預計將從合作夥伴關係中受益，包括提高生產力、提高品質標準、縮短上市時間、降低整體擁有成本（TCO）和降低供應鏈風險。2022年 7月，醫療設備製造公司 Nipro Corporation Japan 投資 1 億克羅埃西亞庫納（1,360 萬美元/1,330 萬歐元）在克羅埃西亞為製藥業新建一座玻璃包裝廠。生產用於包裝救生藥物的玻璃安瓿和小瓶的新工廠在薩格勒布郊區 Sesvete 落成，該工廠隸屬於 Nipro PharmaPackaging 部門。

附加優惠：

  • Excel 格式的市場估算（ME）表
  • 3 個月的分析師支持

目錄

第1章 簡介

  • 研究假設和市場定義
  • 研究範圍

第2章 研究方法

第3章 執行摘要

第4章 市場洞察

  • 市場概況
  • 產業價值鏈分析
  • 產業吸引力 - 波特五力
    • 供應商的議價能力
    • 買家/消費者的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭激烈程度
  • COVID-19 對產業影響的評估

第5章 市場動態

  • 市場促進因素
    • 新興經濟體製藥業的成長
    • 玻璃的商品價值因可回收性而增加
  • 市場限制
    • 替代材料的相關性增加

第6章 市場細分

  • 產品
    • 瓶子
    • 小瓶
    • 安瓿
    • 墨水匣和注射器
    • 其他產品
  • 地理
    • 北美洲
      • 美國
      • 加拿大
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 歐洲其他地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 亞太地區其他地區
    • 拉丁美洲
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地區
    • 中東和非洲
      • 沙烏地阿拉伯
      • 南非
      • 中東和非洲其他地區

第7章 競爭格局

  • 公司簡介
    • Gerresheimer AG
    • Corning Incorporated
    • Nipro Corporation
    • SGD SA（SGD PHARMA）
    • Stlzle-Oberglas GmBH（CAG Holding GmbH）
    • Bormioli Pharma SpA
    • West Pharmaceutical Services Inc
    • Schott AG
    • Shandong Medicinal Glass Co. Ltd
    • Beatson Clark
    • Arab Pharmaceutical Glass Co.
    • Piramal Glass Private Limited（Piramal Group）
    • Sisecam Group

第8章 投資分析

第9章 市場機會與未來趨勢

簡介目錄
Product Code: 66844

The Pharmaceutical Glass Packaging Market size is estimated at USD 29.77 billion in 2024, and is expected to reach USD 38.52 billion by 2029, growing at a CAGR of 5.29% during the forecast period (2024-2029).

Pharmaceutical Glass Packaging - Market

Glass packaging solutions are offered mainly as the primary packaging for pharmaceutical products and are among the leading packaging materials for the pharmaceutical industry. This is mainly due to being sustainable, inert, impermeable, and recyclable with no loss in quality and reusable advantages.

Key Highlights

  • The increasing demand for pharmaceutical drugs and medicines associated with technological advancements in the pharmaceutical industry is directly creating the demand for bottles, ampules, and other glass packaging solutions.
  • With a rise in chronic diseases and a significant number of vaccine doses being manufactured for COVID-19, the demand for primary packaging is anticipated to rise, especially glass containers.
  • Moreover, The significant characteristic benefits of glass, such as chemically durable and suitability to sustain various chemical compositions, are some factors driving packaging vendors to choose glass as pharmaceutical material. Additionally, glass vials and ampoules offer improved transparency, making viewing and monitoring the contents.
  • Traditionally, the preferred materials across pharmaceutical packaging have been aluminum and glass. Over time, these materials became expensive due to raw material prices and other factors and could not provide economically viable solutions for packaging products across mass consumption. That marked the advent of plastics as an option.
  • The COVID-19 pandemic left a steady growth rate with increased demand for medicines. The surge in demand for pharmaceutical drugs during the pandemic has driven the market's growth. It is expected to grow as new drugs and vaccines are being approved and phased out in different countries by pharmaceutical manufacturers, expanding the scope of glass packaging.

Pharmaceutical Glass Packaging Market Trends

Growth of Pharmaceutical Industry in Emerging Economies to Drive Growth

  • Emerging markets are described as growing prosperous nations where investment is anticipated to increase profits despite significant risks. The BRICS (Brazil, Russia, India, China, and South Africa) nations are the top developing economies. There are a few different approaches to classifying lower-tier economies. One only uses a select few as the MIST (Mexico, Indonesia, South Korea, and Turkey). Another interpretation separates the two groups into CIVETS (Colombia, Indonesia, Vietnam, Egypt, Turkey, and South Africa) and Bangladesh, Egypt, Indonesia, Iran, Korea, Mexico, Nigeria, Pakistan, the Philippines, Turkey, and Vietnam.
  • While pharmaceutical sales grow slowly in many developed nations, emerging market sales patterns indicate ongoing expansion. Several economic and demographic variables influence the trend in these markets, such as challenging conditions in established markets, with which growth has been flattened due to patent expiration, cost-cutting measures that encourage generic replacement, and strict enforcement of restrictions.
  • The pharmaceutical glass packaging industry has seen significant penetration in nations like China. Glass packaging for pharmaceuticals is becoming more widely used in developed countries. As a result of COVID-19, the healthcare and pharmaceutical sectors are growing in emerging nations, which presents the potential for the Chinese market for pharmaceutical glass packaging.
  • For instance, in September 2022, SCHOTT Pharma expanded cartridge output in China. Several million investments are intended to significantly improve the manufacturing capabilities for pharmaceutical cartridges in China and Hungary.
  • Additionally, R&D was highly valued in the pharmaceutical sector in India. India became a worldwide medical giant in 2022 by enlarging its R&D ecosystem and raising pharmaceutical exports, creating opportunities for various domestic glass packaging vendors.
  • Overall, all these investments by significant market incumbents due to the growth of the pharmaceutical market are expected to drive market growth in the forecast period.

Asia Pacific to Witness Significant Growth

  • China's pharmaceutical glass packaging market is expected to grow very fast as China has built a standard system for the pharmaceutical industry over the years. The country pays more and more attention to the stability of pharmaceutical packaging materials during the drug storage period and safety when used. Against this background, new types of green, degradable, and easy-to-use pharmaceutical packaging materials and vessels are in the palmy days.
  • China's large and rapidly growing healthcare market has been an obvious target of opportunity for the glass packaging sector in China due to the presence of major multinational pharmaceutical companies, and these companies are among the most significant revenue earners in the Chinese pharmaceutical market.
  • In India, pharmaceutical glass packaging has been growing due to the increasing usage of generic injectable drugs in the healthcare industry. Pharmaceutical glass packaging is available in various drug types, such as injectable and non-injectable. The significant property of pharmaceutical glass packaging has high chemical durable properties, which maximizes the reliability of the products.
  • The demand for glass packaging in India is expected to grow rapidly as India is a prominent and expanding player in the global medicines market. According to data published on the India Brand Equity Foundation website, India is the world's largest provider of generic pharmaceuticals, accounting for 20% of the worldwide supply and meeting over 60% of global vaccine demand. The Indian pharmaceutical industry is valued at USD 42 billion globally. The Indian pharmaceutical market expanded by 17.7% Y-o-Y in August 2021, up from 13.7% in July 2020. According to India Ratings & Research, the Indian pharmaceutical market revenue will increase by more than 12% in FY22.
  • In Japan, the market's growth is supported by the increase in glass container shipments in end-use markets. Glass containers are one of the most preferred materials for packaging liquid-based pharmaceutical products, chemicals, and a variety of other perishable/non-perishable products. Moreover, the rising preference for environment-friendly packaging solutions impacts pharmaceutical glass packaging adoption.
  • The scope of the Rest of the Asia-Pacific region includes multiple countries such as Indonesia, Australia, Singapore, Thailand, South Korea, and Malaysia. The market is driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations, and a robust generics market.

Pharmaceutical Glass Packaging Industry Overview

The pharmaceutical glass packaging market is inclined towards fragmentation. The surge in government initiatives and increasing demand for injectables and other medicines provide lucrative pharmaceutical glass packaging solutions opportunities. Overall, the competitive rivalry among existing competitors is high. Further, expansion and mergers of large companies in different pharmaceutical industries are expected to increase the demand in the market. Key players are Gerresheimer Glass Inc., Corning Incorporated, etc.

In September 2022, Gerresheimer AG and StevanatoGroup SpA developed together a high-end ready-to-use (RTU) solution platform with an initial focus on vials built on StevanatoGroup's market-leading EZ-fill technology. The customers are expected to benefit from the partnership in terms of increased productivity, higher quality standards, quicker time to market, the lower total cost of ownership (TCO), and reduced supply chain risk. In July 2022, Nipro Corporation Japan, a Medical equipment manufacturing company, invested HRK 100 million (USD 13.6 million/EUR 13.3 million) in a new glass packaging plant for the pharmaceutical industry in Croatia. The new factory that produces glass ampoules and vials to package life-saving drugs was inaugurated in Zagreb's suburb Sesvete, Nipro's division Nipro PharmaPackaging.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter Five Forces
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Buyers/Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitutes
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Assessment of Impact of COVID-19 on the Industry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Growth of Pharmaceutical Industry in Emerging Economies
    • 5.1.2 Commodity Value of Glass Increased with Recyclability
  • 5.2 Market Restraints
    • 5.2.1 Increased Relevance of Alternate Material

6 MARKET SEGMENTATION

  • 6.1 Product
    • 6.1.1 Bottles
    • 6.1.2 Vials
    • 6.1.3 Ampoules
    • 6.1.4 Cartridges and Syringes
    • 6.1.5 Others Products
  • 6.2 Geography
    • 6.2.1 North America
      • 6.2.1.1 United States
      • 6.2.1.2 Canada
    • 6.2.2 Europe
      • 6.2.2.1 Germany
      • 6.2.2.2 United Kingdom
      • 6.2.2.3 France
      • 6.2.2.4 Italy
      • 6.2.2.5 Rest of Europe
    • 6.2.3 Asia Pacific
      • 6.2.3.1 China
      • 6.2.3.2 India
      • 6.2.3.3 Japan
      • 6.2.3.4 Rest of Asia Pacific
    • 6.2.4 Latin America
      • 6.2.4.1 Brazil
      • 6.2.4.2 Argentina
      • 6.2.4.3 Rest of Latin America
    • 6.2.5 Middle East and Africa
      • 6.2.5.1 Saudi Arabia
      • 6.2.5.2 South Africa
      • 6.2.5.3 Rest of Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Gerresheimer AG
    • 7.1.2 Corning Incorporated
    • 7.1.3 Nipro Corporation
    • 7.1.4 SGD SA (SGD PHARMA)
    • 7.1.5 Stlzle-Oberglas GmBH (CAG Holding GmbH)
    • 7.1.6 Bormioli Pharma SpA
    • 7.1.7 West Pharmaceutical Services Inc
    • 7.1.8 Schott AG
    • 7.1.9 Shandong Medicinal Glass Co. Ltd
    • 7.1.10 Beatson Clark
    • 7.1.11 Arab Pharmaceutical Glass Co.
    • 7.1.12 Piramal Glass Private Limited (Piramal Group)
    • 7.1.13 Sisecam Group

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS